Stifel Financial’s Armata Pharmaceuticals ARMP Stock Holding History

Stifel Financial’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-19,729	Closed	-$59K	–	3205
2020 Q4	$59K	Hold	19,729	–	–	﹤0.01%	2971
2020 Q3	$63K	Hold	19,729	–	–	﹤0.01%	2794
2020 Q2	$77K	Sell	19,729 -2,870	-13%	-$9.95K	﹤0.01%	2742
2020 Q1	$70K	Hold	22,599	–	–	﹤0.01%	2631
2019 Q4	$73K	Hold	22,599	–	–	﹤0.01%	2910
2019 Q3	$84K	Buy	+22,599	New	+$88.9K	﹤0.01%	2779
2019 Q2	–	Sell	-7,600	Closed	-$32K	–	2963
2019 Q1	$32K	Buy	+7,600	New	+$28.9K	﹤0.01%	2760

Other funds holding ARMP

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SWM

SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return

Stifel Financial's ARMP Position: Q1 2021 in Review

Stifel Financial sold out of Armata Pharmaceuticals (ARMP) in Q1 2021, closing a stake of 19,729 shares — an estimated $59K sold.

Stifel Financial first reported a position in ARMP in Q1 2019 and held it in 7 quarters. The position peaked at $84K in Q3 2019. 23 funds tracked by Wall St. Rank hold ARMP as of Q1 2021.

Stifel Financial reported no remaining Armata Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Stifel Financial sold 19,729 Armata Pharmaceuticals shares in Q1 2021, an estimated $59K.
Stifel Financial first reported a position in Armata Pharmaceuticals in Q1 2019 and held it in 7 quarters.
Stifel Financial's Armata Pharmaceuticals position peaked at $84K in Q3 2019.
23 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2021.

Based on Stifel Financial's 13F filing for Q1 2021, filed 14 May 2021.